Skip to main content
Clinical Trials/NCT04637880
NCT04637880CompletedNot Applicable

25- Hydroxyvitamin D Levels in Pregnancy and Effects on Pregnancy Related Disorders

Medical University of Vienna1 site in 1 country249 target enrollmentStarted: July 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
249
Locations
1
Primary Endpoint
25- Hydroxyvitamin D and relation to development of preeclampsia

Study Overview

Brief Summary

Evaluation of 25- Hydroxyvitamin D levels in pregnant women in Austria and potential related disorders

Hypothesis:

Austrian pregnant women are Vitamin D deficient Present vitamin D supplementation in pregnancy is insufficient Vitamin D deficiency is associated with pregnancy related disorders like preeclampsia

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age> 18 years
  • informed consent

Exclusion Criteria

  • chronic hypertension
  • kidney disease
  • lupus erythematodes
  • diabetes mellitus
  • malabsorption syndrome
  • hyperparathyroidism
  • surgery on the thyroid gland

Outcomes

Primary Outcomes

25- Hydroxyvitamin D and relation to development of preeclampsia

Time Frame: over course of pregnancy

Secondary Outcomes

  • 25 Hydroxyvitamin D in newborn(once at delivery)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Julia Wild, MD

Dr. med. univ

Medical University of Vienna

Study Sites (1)

Loading locations...

Similar Trials